Does canagliflozin normalize postprandial hyperglycemia and restore glucose effectiveness in Zucker diabetic fatty rats by promoting glucokinase translocation?
What the Evidence Shows
We analyzed one study on Zucker diabetic fatty rats and found that daily doses of canagliflozin for one week were associated with lower blood sugar after meals and improved how the liver handles glucose. The study suggests this effect may be linked to glucokinase — an enzyme that helps liver cells...
Evidence from Studies
Supporting (0)
No supporting evidence found
Contradicting (0)
No contradicting evidence found
Primary Studies (1)
Update History
Published
May 31, 2026·Last updated May 31, 2026- Invalid DateNew topic created from assertion